Releaf Curcumin 185, which is 185 times more bioavailable than standard Curcumin extract, is used to assist with the relief of joint pain and inflammation associated with osteoarthritis. Releaf Curcumin 185 is a powerful antioxidant
HS300450 - Medicaments; containing vitamins or their derivatives; for therapeutic or prophylactic use; packaged for retail sale
| Product or Service Certification |
|---|
Company Name: Enygma Capital
Company Address: Kleine Parys Estate 2 Unit 80 Carolina road Kleine Parys, 7646, South Africa
Company General Phone: +27 82 657 8268
Company General Mail: pascal@enygmacapital.com
Company Website: www.enygmacapital.com
Key Contact: Christian Nel
Key Contact Phone: +27 82 657 8268
Key Contact General Mail: pascal@enygmacapital.com
Incorporation Date: June 10, 2020
BEE: BEE Level 4
Woman-Owned: No
Company Size: 1 – 5
Distribution: Retail , Bulk , Export via Sea , Export via Air Freight , E-Commerce
Company Overview: Enygma Capital is a Business Development Company. We source and distribute products for clients
Year Started Exporting: |
Not Yet Exporting |
Countries Currently Exporting to: |
None |
Countries Hoping to Export to: |
France, Germany, Russia, South Africa, United Arab Emirates, United Kingdom, United States |
Registered Under the Following Trade Agreements: |
None |
Notifications
